| TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ... Nature communications 11 (1), 6315, 2020 | 150 | 2020 |
| Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria C Lai, N Pursell, J Gierut, U Saxena, W Zhou, M Dills, R Diwanji, C Dutta, ... Molecular Therapy 26 (8), 1983-1995, 2018 | 112 | 2018 |
| In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment A Ohta, R Diwanji, R Kini, M Subramanian, A Ohta, M Sitkovsky Frontiers in immunology 2, 27, 2011 | 102 | 2011 |
| Inhibition of glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1 C Dutta, N Avitahl-Curtis, N Pursell, ML Cohen, B Holmes, R Diwanji, ... Molecular Therapy 24 (4), 770-778, 2016 | 95 | 2016 |
| Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo H Dudek, DH Wong, R Arvan, A Shah, K Wortham, B Ying, R Diwanji, ... Molecular Therapy 22 (1), 92-101, 2014 | 71 | 2014 |
| Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus A Gardet, A Pellerin, CA McCarl, R Diwanji, W Wang, D Donaldson, ... Frontiers in immunology 10, 275, 2019 | 42 | 2019 |
| Inhibition of glycogen synthase II with RNAi prevents liver injury in mouse models of glycogen storage diseases N Pursell, J Gierut, W Zhou, M Dills, R Diwanji, M Gjorgjieva, U Saxena, ... Molecular Therapy 26 (7), 1771-1782, 2018 | 34 | 2018 |
| Targeting the IL1β pathway for cancer immunotherapy remodels the tumor microenvironment and enhances antitumor immune responses R Diwanji, NA O'Brien, JE Choi, B Nguyen, T Laszewski, AL Grauel, Z Yan, ... Cancer Immunology Research 11 (6), 777-791, 2023 | 18 | 2023 |
| Targeting the IL-1beta pathway for cancer immunotherapy remodels the tumor microenvironment and enhances antitumor immune responses. Cancer Immunol Res. 2023 R Diwanji, NA O’Brien, JE Choi | 6 | |
| Abstract C103: Targeting IL-1β pathway for cancer immunotherapy P Jayaraman, J Millholland, N O’Brien, C Wong, R Diwanji, M Wang, ... Molecular Cancer Therapeutics 18 (12_Supplement), C103-C103, 2019 | 5 | 2019 |
| Abstract B20: EnCore-LNP mediated tumor delivery of MYC and CTNNB1 Dicer Substrate RNAs (DsiRNAs) M Abrams, S Ganesh, B Ying, G Chopda, U Saxena, A Shah, M Koser, ... Molecular Cancer Therapeutics 13 (10_Supplement), B20-B20, 2015 | 5 | 2015 |
| Targeting tumor-promoting inflammation (TPI) via the IL-1βpathway for cancer immunotherapy P Jayaraman, V Rodrik-Outmezguine, J Millholland, N O'Brien, C Wong, ... Cancer Research 80 (16_Supplement), 5640-5640, 2020 | 4 | 2020 |
| Anti IL-1b as a cancer immunotherapy. R Singh, R Diwanji, P Jayaraman, D Chiang, C Sabatos-Peyton, ... CANCER IMMUNOLOGY RESEARCH 8 (4), 73-73, 2020 | 2 | 2020 |
| Abstract B222: Dicer substrate siRNAs to MYC, B-catenin, and other target genes effectively induce in vivo target gene knockdown and tumor inhibition. H Dudek, K Wortham, R Arvan, A Shah, B Ying, W Cyr, H Yang, W Zhou, ... Molecular Cancer Therapeutics 12 (11_Supplement), B222-B222, 2013 | 1 | 2013 |
| Dicer substrate siRNAs to MYC, B-catenin, and other target genes effectively induce in vivo target gene knockdown and tumor inhibition. H Dudek, K Wortham, R Aryan, A Shah, B Ying, W Cyr, H Yang, W Zhou, ... MOLECULAR CANCER THERAPEUTICS 12 (11), 2013 | 1 | 2013 |
| Abstract A76: Anti IL-1b as a cancer immunotherapy R Singh, R Diwanji, P Jayaraman, D Chiang, C Sabatos-Peyton, ... Cancer Immunology Research 8 (4_Supplement), A76-A76, 2020 | | 2020 |
| AB0043 EFFECT OF IN VIVO HYDROXYCHLOROQUINE AND EX VIVO ANTI-BDCA2 TREATMENT ON PDC IFNα PRODUCTION FROM PATIENTS AFFECTED WITH CUTANEOUS LUPUS ERYTHEMATOSUS A Gardet, A Pellerin, CA Mccarl, R Diwanji, W Wang, D Donaldson, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1488-1488, 2019 | | 2019 |
| Evaluation of Glyoxylate and Hydroxyproline Metabolic Pathways Through the Use of Dicer-Substrate Small Interfering RNA N Avitahl-Curtis, B Holmes, L Apponi, R Diwanji, MSL Cohen, C Dutta, ... HEPATOLOGY 62, 464A-464A, 2015 | | 2015 |
| Dicer-Substrate Small RNAs as Potential Therapeutics for Hepatic Diseases NW Pursell, R Diwanji, UH Saxena, H Dudek, N Avitahl-Curtis, C Dutta, ... HEPATOLOGY 62, 1238A-1239A, 2015 | | 2015 |
| 358 Knockdown of beta-catenin with dicer-substrate siRNAs down-regulates Wnt/beta-catenin pathway signaling N Pursell, W Zhou, R Diwanji, B Holmes, N Avitahl-Curtis, C Dutta, ... European Journal of Cancer, 115-116, 2014 | | 2014 |
